BMPR1A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.755600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.936400E-01
Normal-vs-Stage2
5.627600E-01
Normal-vs-Stage3
2.341200E-01
Normal-vs-Stage4
9.859600E-01
Stage1-vs-Stage2
2.729600E-01
Stage1-vs-Stage3
5.755900E-02
Stage1-vs-Stage4
8.584800E-01
Stage2-vs-Stage3
1.310230E-01
Stage2-vs-Stage4
5.309400E-01
Stage3-vs-Stage4
1.898980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.390800E-01
Normal-vs-AfricanAmerican
8.790400E-01
Normal-vs-Asian
6.980800E-01
Caucasian-vs-AfricanAmerican
2.360200E-01
Caucasian-vs-Asian
8.854000E-01
AfricanAmerican-vs-Asian
4.306400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.542000E-01
Normal-vs-Female
6.362000E-01
Male-vs-Female
5.130600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.209000E-01
Normal-vs-Age(41-60Yrs)
8.625600E-01
Normal-vs-Age(61-80Yrs)
5.346800E-01
Normal-vs-Age(81-100Yrs)
5.242400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.354200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.548200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.381200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.649500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.993600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.315000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.410200E-01
Normal-vs-Daily Drinker
3.421600E-01
Normal-vs-Weekly Drinker
5.826000E-01
Normal-vs-Occasional Drinker
9.105000E-01
Normal-vs-Social Drinker
9.382000E-01
Non Drinker-vs-Daily Drinker
5.595200E-01
Non Drinker-vs-Weekly Drinker
6.786800E-01
Non Drinker-vs-Occasional Drinker
8.594100E-02
Non Drinker-vs-Social Drinker
2.348200E-01
Daily Drinker-vs-Weekly Drinker
4.512600E-01
Daily Drinker-vs-Occasional Drinker
6.668100E-02
Daily Drinker-vs-Social Drinker
1.307010E-01
Weekly Drinker-vs-Occasional Drinker
3.465400E-01
Weekly Drinker-vs-Social Drinker
4.546000E-01
Occasional Drinker-vs-Social Drinker
9.910600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.980000E-02
Normal-vs-Grade 2
8.476700E-03
Normal-vs-Grade 3
7.482700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.580400E-01
Grade 1-vs-Grade 3
3.950400E-01
Grade 1-vs-Grade 4
4.980000E-02
Grade 2-vs-Grade 3
9.702000E-01
Grade 2-vs-Grade 4
8.476700E-03
Grade 3-vs-Grade 4
7.482700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.551400E-01
Normal-vs-NonDiabetic
5.312800E-01
Diabetic-vs-NonDiabetic
3.333600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.388000E-01
Normal-vs-NoPancreatitis
4.797200E-01
Pancreatitis-vs-NoPancreatitis
4.665800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.000600E-01
Normal-vs-N1
5.659600E-01
N0-vs-N1
9.709600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.547600E-01
Normal-vs-TP53-NonMutant
9.060000E-01
TP53-Mutant-vs-TP53-NonMutant
8.537400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
